In a study reported Thursday, a medicine from Bristol Myers Squibb nearly doubled the treatment benefit compared to standard therapy for certain patients with
Tag - cancer
In 2023, just under 2 million Americans will be diagnosed with cancer. Many will endure multiple CT and MRI studies and intensive medical care, including
WASHINGTON — President Biden’s presumed pick to lead the National Institutes of Health, Monica Bertagnolli, will face a slew of questions on the multibillion
Despite decades of advancements in genomics, we still don’t know what most of our DNA does. But an ambitious international research collaboration is providing
Clinicians know the odds tend to be stacked against Black breast cancer patients. They have more dangerous and aggressive subtypes of breast cancer more
WASHINGTON — All U.S. women getting mammograms will soon receive information about their breast density, which can sometimes make cancer harder to spot. The
A U.S. government watchdog found that Medicare drug plans improperly authorized thousands of prescriptions for certain powerful opioids over a recent four-year
When breast oncologists see new patients, one of their hopes is that the patient doesn’t have triple-negative breast cancer. The subtype is considered
Bay Area biotech Guardant Health on Thursday announced results from a massive trial of its blood-based test for the early detection of colon cancer that, while
Medicines that reshape or tamp down immune responses may be life-changing for patients with cancer and autoimmune disorders, but in some cases they can awaken
